镰状细胞病：当前认识与未来选择
Sickle Cell Disease: Current Understanding and Future Options.
作者信息
Varelas Christos, Gavriilaki Eleni
机构信息
Hematology Department-BMT Unit, G .Papanicolaou Hospital, 57010 Thessaloniki, Greece.
2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 54644 Thessaloniki, Greece.
出版信息
J Clin Med. 2023 Sep 13;12(18):5943. doi: 10.3390/jcm12185943.
Abstract
Sickle cell disease (SCD) is a prevalent inherited hemoglobin disorder encompassing a cluster of congenital hemolytic anemias, each distinguished by the prevalence of sickle hemoglobin (HbS) [...].
摘要
镰状细胞病（SCD）是一种常见的遗传性血红蛋白疾病，包括一系列先天性溶血性贫血，每种贫血都以镰状血红蛋白（HbS）的 prevalence[... ]为特征。 （注：原文中“prevalence”此处表述似乎有误，可能影响对整句准确理解，正常可能是“presence”之类的词，可根据实际情况调整）
相似文献
1
Sickle Cell Disease: Current Understanding and Future Options.
J Clin Med. 2023 Sep 13;12(18):5943. doi: 10.3390/jcm12185943.
2
Current modalities of sickle cell disease management.
Blood Sci. 2020 Aug 27;2(4):109-116. doi: 10.1097/BS9.0000000000000056. eCollection 2020 Oct.
3
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
J Blood Med. 2021 Mar 23;12:177-187. doi: 10.2147/JBM.S287301. eCollection 2021.
4
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0.
5
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
Blood. 2022 Aug 18;140(7):769-781. doi: 10.1182/blood.2021014716.
6
Modeling the public health impact of voxelotor in the management of sickle cell disease in France.
PLoS One. 2023 Sep 13;18(9):e0291211. doi: 10.1371/journal.pone.0291211. eCollection 2023.
7
Chronic Pulmonary Complications of Sickle Cell Disease.
Chest. 2016 May;149(5):1313-24. doi: 10.1016/j.chest.2015.11.016. Epub 2016 Jan 13.
8
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):207-15. doi: 10.2215/CJN.03940415. Epub 2015 Dec 15.
9
Sickle cell diseases: What can nuclear medicine offer?
Hell J Nucl Med. 2019 Jan-Apr;22(1):2-3. doi: 10.1967/s002449910950. Epub 2019 Mar 7.
10
Established and experimental treatments for sickle cell disease.
Haematologica. 2004 Mar;89(3):348-56.
引用本文的文献
1
Cardiovascular Anesthesia and Critical Care in the French West Indies: Historical Evolution and Current Prospects.
J Clin Med. 2025 Jan 13;14(2):459. doi: 10.3390/jcm14020459.
2
The Management of Postpartum Cardiorespiratory Failure in a Patient with COVID-19 and Sickle Cell Trait Requiring Extraorporeal Membrane Oxygenation Support and Airflight Transportation.
J Clin Med. 2025 Jan 2;14(1):213. doi: 10.3390/jcm14010213.
本文引用的文献
1
Mitochondria: Emerging Consequential in Sickle Cell Disease.
J Clin Med. 2023 Jan 18;12(3):765. doi: 10.3390/jcm12030765.
2
COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic.
J Clin Med. 2022 Dec 12;11(24):7361. doi: 10.3390/jcm11247361.
3
Rate of Dental Extractions in Patients with Sickle Cell Disease.
J Clin Med. 2022 Oct 19;11(20):6174. doi: 10.3390/jcm11206174.
4
Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study.
J Clin Med. 2022 Feb 23;11(5):1193. doi: 10.3390/jcm11051193.
5
Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center.
J Clin Med. 2022 Feb 11;11(4):937. doi: 10.3390/jcm11040937.
6
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
J Blood Med. 2021 Mar 23;12:177-187. doi: 10.2147/JBM.S287301. eCollection 2021.
7
Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing.
Blood Rev. 2021 Jul;48:100805. doi: 10.1016/j.blre.2021.100805. Epub 2021 Jan 21.
8
Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
Hemoglobin. 2018 Sep-Nov;42(5-6):339-341. doi: 10.1080/03630269.2018.1540353. Epub 2019 Jan 9.
9
Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia.
Case Rep Hematol. 2014;2014:213631. doi: 10.1155/2014/213631. Epub 2014 Feb 9.
Zotero 插件